首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
【24h】

Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.

机译:急性d-苯丙胺预处理不会改变人类的兴奋性自我给药。

获取原文
获取原文并翻译 | 示例
           

摘要

Recent clinical research indicates that d-amphetamine is effective in treating cocaine and methamphetamine dependence. There is concern, however, with the use of d-amphetamine as a pharmacotherapy because acute administration of d-amphetamine decreases inhibition in cocaine-using individuals and may increase drug-taking behavior. The purpose of the present experiment was to determine whether acute d-amphetamine pretreatment would alter the reinforcing, subject-rated, and cardiovascular effects of d-amphetamine. To this end, 7 human volunteers first sampled doses of oral d-amphetamine (0, 8, and 16 mg). These doses engender moderate drug taking and were selected to avoid a ceiling or floor effect. Volunteers were then allowed to self-administer these sampled doses using a modified progressive-ratio procedure in two sessions in which they received pretreatment with either 0 or 15 mg oral d-amphetamine 2 h prior to completing the modified progressive-ratio procedure. d-Amphetamine produced prototypical stimulant-like effects (e.g., increased ratings of stimulated, elevated blood pressure) and maintained responding on the modified progressive-ratio schedule. Pretreatment with 15 mg oral d-amphetamine also produced prototypical stimulant-like effects, but failed to alter break points for d-amphetamine on the modified progressive-ratio procedure relative to placebo pretreatment. These results indicate that acute d-amphetamine pretreatment does not increase stimulant self-administration.
机译:最近的临床研究表明,d-苯异丙胺对治疗可卡因和甲基苯丙胺依赖性有效。然而,使用d-苯异丙胺作为药物治疗是令人关注的,因为d-苯异丙胺的急性给药降低了使用可卡因的个体的抑制作用,并且可能增加了吸毒行为。本实验的目的是确定急性d-苯丙胺的预处理是否会改变d-苯丙胺的增强作用,受试者评定的和心血管作用。为此,有7位人类志愿者首先采样了口服d-苯异丙胺的剂量(0、8和16 mg)。这些剂量会导致中度服用药物,因此选择这些剂量以避免产生天花板或地板效应。然后让志愿者在两个疗程中使用改良的逐步配比程序自行施用这些采样剂量,在此过程中,他们在完成改良的逐步配比程序之前2小时接受0或15 mg口服d-苯丙胺的预处理。 d-苯丙胺产生了典型的兴奋剂样作用(例如,刺激的额定值升高,血压升高),并在修改的渐进比例表上保持响应。与安慰剂预处理相比,用15 mg口服d-苯异丙胺进行的预处理也可产生原型兴奋剂样效果,但未能改变d-苯异丙胺在改良的逐步配比程序上的折点。这些结果表明,急性d-苯丙胺预处理不会增加兴奋剂的自我给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号